EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of glycocalyx-targeted therapy on vascular function in older adults: a randomized controlled trial

Colin J Gimblet iD, Jackson W Ernst, Blair Bell, Kyle D Bos, Amy K Stroud, Linder H Wendt, Anthony J Donato, Diana I Jalal iD, Gary L Pierce iD

Journal of Applied Physiology · 01.06.2024 · 136 (6) · 1488-1495

DOI: 10.1152/japplphysiol.00150.2024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Applied Physiology, erschienen am 01.06.2024. Verfasst von Colin J Gimblet und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Human Physiology, University of Iowa, Iowa City, Iowa, United States. Hauptthemen laut MEDLINE: Glycocalyx, Endothelium, Vascular, Brachial Artery. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, American Heart Association (AHA), Russel B. Day and Florence D. Day Endowed Chair in Liberal Arts and Sciences fund at the University of Iowa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial glycocalyx thickness and vascular endothelial function decline with advancing age. Endocalyx Pro is a glycocalyx-targeted therapy that may improve endothelial glycocalyx thickness and vascular endothelial function in older adults. This study demonstrated that 12-wk Endocalyx Pro supplementation did not improve overall endothelial glycocalyx thickness or flow-mediated dilation in older adults; however, Endocalyx Pro did increase capillary glycocalyx thickness in individuals not taking antihypertensive medication and improve flow-mediated dilation normalized to the shear stimulus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycocalyxEndothelium, VascularBrachial ArteryHumansFemaleMaleAgedDouble-Blind MethodVasodilationMiddle AgedCardiovascular Diseases

Stichwörter der Autor:innen

endocalyxendotheliumglycocalyx

Autor:innen und Institutionen

  • Department of Health and Human Physiology, University of Iowa, Iowa City, Iowa, United States.
  • Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa, United States.
  • Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States.
  • Iowa City VA Medical Center, Iowa City, Iowa, United States.

ORCID-Profile: Colin J Gimblet, Diana I Jalal, Gary L Pierce

Förderung

  • American Heart Association-American Stroke Association
  • American Heart Association (AHA)
  • Russel B. Day and Florence D. Day Endowed Chair in Liberal Arts and Sciences fund at the University of Iowa

Zitieren

APA

Gimblet, C. J., Ernst, J. W., Bell, B., Bos, K. D., Stroud, A. K., Wendt, L. H., Donato, A. J., Jalal, D. I., & Pierce, G. L. (2024). Effect of glycocalyx-targeted therapy on vascular function in older adults: a randomized controlled trial. Journal of Applied Physiology, 136(6), 1488-1495. https://doi.org/10.1152/japplphysiol.00150.2024

Vancouver

Gimblet CJ, Ernst JW, Bell B, Bos KD, Stroud AK, Wendt LH, et al. Effect of glycocalyx-targeted therapy on vascular function in older adults: a randomized controlled trial. Journal of Applied Physiology. 2024;136(6):1488-1495. doi:10.1152/japplphysiol.00150.2024

BibTeX
@article{Gimblet2024,
  author = {Gimblet, Colin J and Ernst, Jackson W and Bell, Blair and Bos, Kyle D and Stroud, Amy K and Wendt, Linder H and Donato, Anthony J and Jalal, Diana I and Pierce, Gary L},
  title = {Effect of glycocalyx-targeted therapy on vascular function in older adults: a randomized controlled trial},
  journal = {Journal of Applied Physiology},
  year = {2024},
  volume = {136},
  number = {6},
  pages = {1488--1495},
  doi = {10.1152/japplphysiol.00150.2024}
}
Kostenlos starten →